Evaluate the Prognosis of MYC/TP53 Comutation in Chinese Patients with EGFR-Positive Advanced NSCLC Using Next-Generation Sequencing: A Retrospective Study
Technology in Cancer Research & Treatment（2022）
Key words
MYC,EGFR,non-small-cell lung cancer (NSCLC),TP53,comutation,EGFR tyrosine kinase inhibitors (TKIs),next-Generation sequencing (NGS)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined